ubiquitin conjugating enzyme inhibitors (Mitotix/DuPont)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameubiquitin conjugating enzyme inhibitors (Mitotix/DuPont)
Drug Alias Nameintracellular proteolysis agents (Mitotix/DuPont)p53 degradation inhibitors (Mitotix/DuPont)MTX-25251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein metabolism modulators
TargetsUpdating
Therapy Area/IndicationsUterine Cervical NeoplasmsNeoplasmsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgennix Usa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma CompanyGpc BiotechAgennix Usa Inc
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsNeoplasmsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A